Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts

Journal of Virology

Volumn 82, Issue 13, 2008, Pages 6481-6491

  Yuan, Z Q ^a   Nicolson, L ^a   Marchetti, B ^a   Gault, E A ^a   Campo, M S ^a   Nasir, L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PAPILLOMAVIRUS TYPE 2; CELL TRANSFORMATION; CONTROLLED STUDY; CXCL5 GENE; DOWN REGULATION; FIBROBLAST; FRA 1 GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HORSE; MHC 1 GENE; MICROARRAY ANALYSIS; MMP I GENE; NKG7 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SARCOIDOSIS; SCREENING TEST; TLR4 GENE; UNINDEXED SEQUENCE; VIRUS GENE; VIRUS PATHOGENESIS;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; CELL LINE, TRANSFORMED; DNA PRIMERS; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HORSE DISEASES; HORSES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSCOPY, FLUORESCENCE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PAPILLOMAVIRUS TYPE 2; EQUIDAE;

EID: 45749153802     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00429-08     Document Type: Article

References (70)

1. Akgül, B., R. García-Escudero, L. Ghali, H. J. Pfister, P. G. Fuchs, H. Navsaria, and A. Storey. 2005. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res. 65:2216-2223.
2. Amtmann, E., H. Müller, and G. Sauer. 1980. Equine connective tissue tumors contain unintegrated bovine papillomavirus DNA. J. Virol. 35:962-964.
3. Angeles, J. A., E. Marti, S. Lazary, and L. E. Carmichael. 1991. Characterisation of BPV-like DNA in equine sarcoids. Arch. Virol. 119:95-109.
4. Araibi, E., B. Marchetti, G. H. Ashrafi, and M. S. Campo. 2004. Down-regulation of MHC class I in bovine papillomas. J. Gen. Virol. 85:2809-2814.
5. Ashburner, M., C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, M. A. Harris, D. P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. C. Matese, J. E. Richardson, M. Ringwald, G. M. Rubin, and G. Sherlock for The Gene Ontology Consortium. 2000. Gene ontology: tool for the unification of biology. Nat. Genet. 25:25-29.
6. Ashrafi, G. H., E. Tsirimonaki, B. Marchetti, P. M. O'Brien, G. J. Sibbet, L. Andrew, and M. S. Campo. 2002. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21:248-259.
7. Ashrafi, G. H., M. Haghshenas, B. Marchetti, and M. S. Campo. 2006. E5 protein of human papillomavirus 16 downregulates HLA class 1 and interacts with the heavy chain via its first hydrophobic domain. Int. J. Cancer 119:2105-2112.
8. Balkwill, F. 2004. Cancer and the chemokine network. Nat. Rev. Cancer 4:540-550.
9. Ben-Baruch, A. 2006. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev. 25:357-371.
10. Bogaert, L., M. Van Poucke, C. De Baere, et al. 2007. Bovine papillomavirus load and mRNA expression, cell proliferation and p53 expression in four clinical types of equine sarcoid. J. Gen. Virol. 88:2155-2161.
11. Brain, S. D., and H. M. Cox. 2006. Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br. J. Pharmacol. 147(Suppl. 1):S202-S211.
12. Breitling, R., P. Armengaud, A. Amtmann, and P. Herzyk. 2004. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 573:83-92.
13. Campo, M. S. 2006. Bovine papillomavirus: old system, new lessons?, p. 373-387. In M. S. Campo (ed.), Papillomavirus research: from natural history to vaccines and beyond. Caister Academic Press, Norfolk, United Kingdom. ISBN: 1-904455-04-2.
14. Cao, D., and G. Pizzorno. 2004. Uridine phosphorylase: an important enzyme in pyrimidine metabolism and fluoropyrimidine activation. Drugs Today 40:431-443.
15. Chambers, G., V. A. Ellsmore, P. M. O'Brien, S. W. J. Reid, S. Love, M. S. Campo, and L. Nasir. 2003. Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res. 96:141-145.
16. Cresswell, P., N. Bangia, T. Dick, and G. Diedrich. 1999. The nature of the MHC class 1 peptide loading complex. Immunol. Rev. 172:21-28.
17. Del Vecchio, M., E. Bajetta, S. Canova, M. T. Lotze, A. Wesa, G. Parmiani, and A. Anichini. 2007. Interleukia-12: biological properties and clinical application. Clin. Cancer Res. 13:4677-4685.
18. Deryugina, E. I., and J. P. Quigley. 2006. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25:9-34.
19. Díaz, B., J. Serna, F. De Pablo, and E. J. de la Rosa. 2000. In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis. Development 127:1641-1649.
20. Faure, E., O. Equils, P. A. Sieling, L. Thomas, F. X. Zhang, C. J. Kirschning, N. Polentarutti, M. Muzio, and M. Arditi. 2000. Bacterial lipopolysaccharide activates NF-κB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275:11058-11063.
21. Fusco, A., and M. Fedele. 2007. Roles of HMGA proteins in cancer. Nat. Rev. Cancer 7:899-910.
22. Gasque, P. 2004. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41:1089-1098.
23. Goodrich, L., H. Gerber, E. Marti, and D. F. Antczak. 1998. Equine sarcoids. Vet. Clin. North Am. Equine Pract. 14:607-623.
24. Gordon, G. J., K. Appasani, J. P. Parcells, N. K. Mukhopadhyay, M. T. Jaklitsch, W. G. Richards, D. J. Sugarbaker, and R. Bueno. 2002. Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis 23:1017-1024.
25. Gu, W., and A. L. Bertone. 2004. Generation and performance of an equine-specific large-scale gene expression microarray. Am. J. Vet. Res. 65:1664-1673.
26. Hasan, U. A., C. Caux, I. Perrot, A. C. Doffin, C. Menetrier-Caux, G. Trinchieri, M. Tommasino, and J. Vlach. 2007. Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs. Proc. Natl. Acad. Sci. USA 104:8047-8052.
27. Hofmann, M. A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, M. F. Neurath, T. Slattery, D. Beach, J. McClary, M. Nagashima, J. Morser, D. Stern, and A. M. Schmidt. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides, Cell 97:889-901.
28. Irby, R. B., and T. J. Yeatman. 2000. Role of Src expression and activation in human cancer. Oncogene 19:5636-5656.
29. Kawamura, K., N. Takiguchi, A. Wada, H. Takenobu, H. Kimura, H. Soda, et al. 2006. Up-regulated expression of the uridine phosphorylase gene in human gastric tumors is correlated with a favorable prognosis. Anticancer Res. 26:4647-4651.
30. Kinoshita, T., H. Shirasawa, Y. Shino, K. Shimizu, H. Moriya, and B. Simizu. 1996. Human papillomavirus type 16 E6 protein up-regulates the expression of the high mobility group protein HMG-I(Y) gene in mouse 10T1/2 cells. Virus Res. 42:119-125.
31. Knottenbelt, D. C. 2005. A suggested clinical classification of the equine sarcoid. Clin. Tech. Equine Pract. 4:278-295.
32. Knottenbelt, D. C., and D. F. Kelly. 2000. The diagnosis and management of periorbital sarcoid in the horse; 445 cases from 1974-1999. Vet. Ophthalmol. 3:169-191.
33. Knottenbelt, D. C., and J. A. Walker. 1994. Topical treatment of the equine sarcoid. Equine Vet. Educ. 6:72-75.
34. Kobayashi, Y., Y. Wada, T. Ohara, Y. Okuda, N. Suzuki, K. Hasegawa, K. Kiguchi, and B. Ishizuka. 2007. Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues. Hum. Cell 20:107-110.
35. Kurt-Jones, E. A., L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones, R. A. Tripp, E. E. Walsh, M. W. Freeman, D. T. Golenbock, L. J. Anderson, and R. W. Finberg. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401.
36. -ΔΔCT method. Methods 25:402-408.
37. Löhr, C. V., C. Juan-Sallés, A. Rosas-Rosas, A. Parás García, M. M. Garner, and J. P. Teifke. 2005. Sarcoid in captive zebra (Equus burchellii): association with bovine papillomavirus type 1 infection. J. Zoo Wildlife Med. 36:74-81.
38. Manavi, M., G. Hudelist, A. Fink-Retter, D. Gschwandtler-Kaulich, K. Pischinger, and K. Czerwenka. 2007. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma. Gynecol. Oncol. 105:418-426.
39. Marchetti, B., G. H. Ashrafi, E. Dornan, E. H. Araibi, S. A. Ellis, and M. S. Campo. 2006. The E5 protein of BPV-4 interacts with the heavy chain of MHC class 1 and irreversibly retains the MHC complex in the Golgi apparatus. Oncogene 27:2254-2263.
40. Marchetti, B., G. H. Ashrafi, E. Tsirimonaki, P. M. O'Brien, and M. S. Campo. 2002. The papillomavirus oncoprotein E5 retains the major histocompatibility class 1 in the Golgi apparatus and prevents its transport to the cell surface. Oncogene 21:7808-7816.
41. Martens, A., A. DeMoor, L. Vlaminck, F. Pille, and M. Steenhaut. 2001. Evaluation of excision, cryosurgery and local BCG vaccination for the treatment of equine sarcoids. Vet. Rec. 149:665-669.
42. Medley, Q. G., N. Kedersha, S. O'Brien, Q. Tian, S. F. Schlossman, M. Streuli, and P. Anderson. 1996. Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc. Natl. Acad. Sci. USA 93:685-689.
43. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
44. Miettinen, M., and J. Lasota. 2005. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl. Immunohistochem. Mol. Morphol. 13:205-220.
45. Miyazaki, H., V. Patel, H. Wang, R. K. Edmunds, J. S. Gutkind, and W. A. Yeudall. 2006. Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res. 66:4279-4284.
46. Nasir, L., and S. W. J. Reid. 2006. BPV in equine sarcoids, p. 389-397. In M. S. Campo (ed.), Papillomavirus research: from natural history to vaccines and beyond. Caister Academic Press, Norfolk, United Kingdom. ISBN: 1-904455-04-2.
47. Nasir, L., E. A. Gault, I. M. Morgan, G. Chambers, V. Ellsmore, and M. S. Campo. 2007. Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids. Virology 364:355-361.
48. Nelson, A. R., B. Fingleton, M. L. Rothenberg, and L. M. Matrisian. 2000. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18:1135-1149.
49. Nixon, C., G. Chambers, V. Ellsmore, M. S. Campo, P. Burr, D. J. Argyle, and L. Nasir. 2005. Expression of cell cycle associated proteins cyclin A, CDK-2, p27kip1 and p53 in equine sarcoids. Cancer Lett. 221:237-245.
50. Ofori-Acquah, S. F., and J. A. King. 2008. Activated leukocyte cell adhesion molecule: a new paradox in cancer. Transl. Res. 151:122-128.
51. O'Hayre, M., C. L. Salanga, T. M. Handel, and S. J. Allen. 2008. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem. J. 409:635-649.
52. Park, J. Y., K. H. Park, S. Bang, M. H. Kim, J. E. Lee, J. Gang, S. S. Koh, and S. Y. Song. 2007. CXCL5 overexpression is associated with late stage gastric cancer. J. Cancer Res. Clin. Oncol. 133:835-840.
53. Pascoe, R. R., and P. M. Summers. 1981. Clinical survey of tumours and tumour like lesions in horses in south-east Queensland. Equine Vet. J. 13:325-329.
54. Pierantoni, G. M., C. Rinaldo, M. Mottolese, A. Di Benedetto, F. Esposito, S. Soddu, and A. Fusco. 2007. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. 1. J. Clin. Investig. 117:693-702.
55. Piguet, V. 2005. Receptor modulation in viral replication: HIV, HSV, HHV-8 and HPV: same goal, different techniques to interfere with MHC-I antigen presentation. Curr. Top. Microbiol. Immunol. 285:199-217.
56. Rassa, J. C., J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R. Ross. 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99:2281-2286.
57. Suprynowicz, F. A., A. Baege, I. Sunitha, and R. Schlegel. 2002. c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation. Oncogene 21:1695-1706.
58. Tamm, I., S. M. Kornblau, H. Segall, S. Krajewski, K. Welsh, S. Kitada, D. A. Scudiero, G. Tudor, Y. H. Qui, A. Monks, M. Andreeff, and J. C. Reed. 2000. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res. 6:1796-1803.
59. Tarwid, J. N., P. B. Fretz, and E. G. Clark. 1985. Equine sarcoids: a study with emphasis on pathological diagnosis. Comp. Cont. ed. 7:293-300.
60. Teifke, J. P., M. Hardt, and E. Weiss. 1994. Detection of bovine papillomavirus DNA in formalin-fixed and paraffin-embedded equine sarcoids by polymerase chain reaction and non-radioactive in situ hybridization. Eur. J. Vet. Pathol. 1:5-10.
61. Tower, G. B., C. I. Coon, K. Belguise, D. Chalbos, and C. E. Brinckerhoff. 2003. Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter. Eur. J. Biochem. 270:4216-4225.
62. Tsirimonaki, E., R. Ullah, B. Marchetti, G. H. Ashrafi, L. McGarry, B. Ozanne, and M. S. Campo. 2006. Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells. Virus Res. 115:158-168.
63. Williams, I. F., and A. Heaton. 1982. Connective tissue composition of the equine sarcoid. Equine Vet. J. 14:305-310.
64. Yewdell, J., L. C. Anton, I. Bacik, U. Schubert, H. L. Snyder, and J. R. Bennink. 1999. Generating MHC class I ligands from viral gene products. Immunol. Rev. 172:97-108.
65. Young, M. R., and N. H. Colburn. 2006. Fra-1 a target for cancer prevention or intervention. Gene 379:1-11.
66. Yu, T., Y. C. Peng, and E. J. Androphy. 2007. Mitotic kinesin-like protein 2 binds and colocalizes with papillomavirus E2 during mitosis. J. Virol. 81:1736-1745.
67. Yuan, Z. Q., A. Gallagher, E. A. Gault, M. S. Campo, and L. Nasir. 2007. Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers. Vet. J. 174:599-604.
68. Yuan, Z. Q., A. W. Philbey, E. A. Gault, M. S. Campo, and L. Nasir. 2007. Detection of bovine papillomavirus type 1 genomes and viral gene expression in equine inflammatory skin conditions. Virus Res. 124:245-249.
69. Yuan, Z. Q., E. A. Gault, P. Gobeil, C. Nixon, M. S. Campo, and L. Nasir. 2008. Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology 373:352-361.
70. Zhang, B., Y. Zhang, M. C. Dagher, and E. Shacter. 2005. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res. 65:6054-6062.